Prioritizing research challenges and funding for allergy and asthma and the need for translational research-The European Strategic Forum on Allergic Diseases
Por:
Agache I, Annesi-Maesano I, Bonertz A, Branca F, Cant A, Fras Z, Ingenrieth F, Namazova-Baranova L, Odemyr M, Spanevello A, Vieths S, Yorgancioglu A, Alvaro-Lozano M, Barber Hernandez D, Chivato T, Del Giacco S, Diamant Z, Eguiluz-Gracia I, van Wijk RG, Gevaert P, Graessel A, Hellings P, Hoffmann-Sommergruber K, Jutel M, Lau S, Lauerma A, Maria Olaguibel J, O'Mahony L, Ozdemir C, Palomares O, Pfaar O, Sastre J, Scadding G, Schmidt-Weber C, Schmid-Grendelmeier P, Shamji M, Skypala I, Spinola M, Spranger O, Torres M, Vereda A and Bonini S
Publicada:
1 nov 2019
Ahead of Print:
2 jun 2019
Resumen:
The European Academy of Allergy and Clinical Immunology (EAACI) organized the first European Strategic Forum on Allergic Diseases and Asthma. The main aim was to bring together all relevant stakeholders and decision-makers in the field of allergy, asthma and clinical Immunology around an open debate on contemporary challenges and potential solutions for the next decade. The Strategic Forum was an upscaling of the EAACI White Paper aiming to integrate the Academy's output with the perspective offered by EAACI's partners. This collaboration is fundamental for adapting and integrating allergy and asthma care into the context of real-world problems. The Strategic Forum on Allergic Diseases brought together all partners who have the drive and the influence to make positive change: national and international societies, patients' organizations, regulatory bodies and industry representatives. An open debate with a special focus on drug development and biomedical engineering, big data and information technology and allergic diseases and asthma in the context of environmental health concluded that connecting science with the transformation of care and a joint agreement between all partners on priorities and needs are essential to ensure a better management of allergic diseases and asthma in the advent of precision medicine together with global access to innovative and affordable diagnostics and therapeutics.
Filiaciones:
Agache I:
Transylvania University, Brasov, Romania
Annesi-Maesano I:
Department of Epidemiology of Allergic and Respiratory Diseases, Medical School Saint Antoine, IPLESP, INSERM and Sorbonne Université, Paris, France
Bonertz A:
Federal Agency for Vaccines and Biomedicines, Paul-Ehrlich-Institut, Langen, Germany
Branca F:
Department of Nutrition for Health and Development, Geneva, Switzerland
WHO/HQ, Geneva, Switzerland
Cant A:
University of Newcastle Upon Tyne, Newcastle upon Tyne, UK
European Society for Immunodeficiencies, Geneva, Switzerland
Fras Z:
Division of Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia
Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
UEMS - Union Europeenne des Medecins Specialistes/European Union of Medical Specialists, Brussels, Belgium
Ingenrieth F:
SCOPE Europe, Bruxelles, Belgium
Namazova-Baranova L:
Department of Pediatrics, Russian National Research Medical University of MoH RF, Moscow, Russia
Department of Pediatrics, Central Clinical Hospital of MoSHE (Ministry of Science and High Education), Moscow, Russian Federation
Odemyr M:
European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium
Spanevello A:
Dipartimento di Medicina e Chirurgia, Malattie dell'Apparato Respiratorio, Università degli Studi dell'Insubria, Varese - Como, Italy
Dipartimento di Medicina e Riabilitazione Cardio Respiratoria, U.O. di Pneumologia Riabilitativa, Istituti Clinici Scientifici Maugeri, IRCCS Tradate, Tradate, Italy
Vieths S:
Federal Agency for Vaccines and Biomedicines, Paul-Ehrlich-Institut, Langen, Germany
Yorgancioglu A:
Department of Pulmonology, Celal Bayar University School of Medicine, Manisa, Turkey
Alvaro-Lozano M:
Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu, Barcelona, Barcelona, Spain
Barber Hernandez D:
Department of Basic Medical Sciences, School of Medicine, Universidad CEU San Pablo, Madrid, Spain
RETIC ARADYAL RD16/0006/0015, Instituto de Salud Carlos III, Madrid, Spain
Chivato T:
School of Medicine, University CEU San Pablo, Madrid, Spain
Del Giacco S:
Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy
Diamant Z:
Department of Respiratory Medicine & Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden
Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic
Eguiluz-Gracia I:
Allergy Unit, IBIMA, Regional University Hospital of Malaga, UMA, Malaga, Spain
ARADyAL Network RD16/0006/0001, Carlos III Health Institute, Madrid, Spain
van Wijk RG:
Section of Allergology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands
Gevaert P:
Department of Otorhinolaryngology-Head and Neck Surgery, Upper Airways Research Laboratory, Ghent University, Ghent, Belgium
Graessel A:
Allergy Therapeutics, Worthing, UK
Bencard Allergie GmbH, Munich, Germany
Hellings P:
Department of Otorhinolaryngology-Head and Neck Surgery, Upper Airways Research Laboratory, Ghent University, Ghent, Belgium
Department of Otorhinolaryngology-Head and Neck Surgery, UZ Leuven, Leuven, Belgium
Department of Otorhinolaryngology, Academic Medical Center, Amsterdam, The Netherlands
Hoffmann-Sommergruber K:
Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria
Jutel M:
Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland
"ALL-MED" Medical Research Institute, Wroclaw, Poland
Lau S:
Department for Pediatric Pneumology, Immunology and Intensive Care, Charité Universität Medizin, Berlin, Germany
Lauerma A:
Dermatology and Allergology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
Maria Olaguibel J:
Severe Asthma Unit, Complejo Hospitalario de Navarra, Pamplona, Spain
O'Mahony L:
Departments of Medicine and Microbiology, APC Microbiome Ireland, National University of Ireland, Cork, Ireland
Ozdemir C:
Department of Pediatric Basic Sciences, Institute of Child Health, Istanbul University, Istanbul, Turkey
Department of Pediatrics, Division of Pediatric Allergy & Immunology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
Palomares O:
Department of Biochemistry and Molecular Biology, School of Chemistry, Complutense University of Madrid, Madrid, Spain
Pfaar O:
Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany
Sastre J:
Department of Allergy, Fundación Jimenez Diaz, Madrid, Spain
Department of Medicine, Instituto Carlos III, CIBERES, Universidad Autónoma de Madrid, Madrid, Spain
Scadding G:
RNTNE Hospital, London, UK
Schmidt-Weber C:
Zentrums Allergie & Umwelt (ZAUM), Technische Universität und Helmholtz Zentrum, München, Germany
Schmid-Grendelmeier P:
Allergy Unit, Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
Christine-Kühne Center for Allergy Research and Education CK-CARE Davos, Davos, Switzerland
Shamji M:
Allergy & Clinical Immunology, Inflammation, Repair and Development, Imperial College, National Heart and Lung Institute, Immunomodulation and Tolerance Group, London, UK
Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK
Skypala I:
Royal Brompton & Harefield NHS Foundation Trust, London, UK
Imperial College, London, UK
Spinola M:
European Medical Affairs, Sanofi, Milan, Italy
Spranger O:
Global Allergy and Asthma Patient Platform, Vienna, Austria
Torres M:
Allergy Unit, IBIMA, Regional University Hospital of Malaga, UMA, Malaga, Spain
ARADyAL Network RD16/0006/0001, Carlos III Health Institute, Madrid, Spain
Vereda A:
Aimmune Therapeutics, London, UK
Bonini S:
Institute of Translational Pharmacology, Italian National Research Council, Rome, Italy
Green Submitted
|